Return to homepagePandemic Pact

UK Biobank SARS-CoV-2 Antibody Study

  • Funded by UK Research and Innovation (UKRI)
  • Total publications:0 publications

Grant number: C19-IUC-403

Grant search

Key facts

  • Disease

    COVID-19

  • Funder

    UK Research and Innovation (UKRI)

  • Principal Investigator

    Rory Collins

  • Research Location

    United Kingdom

  • Lead Research Institution

    UK Biobank

  • Research Priority Alignment

    N/A

  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Immunity

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

UKB intends to send out antibody tests to all 500,000 participants in Q1 2021. These lateral flow tests will identify whether participants have antibodies to SARS-CoV-2 within about 15 minutes. Participants will inform UK Biobank of their result so that we can make these data available to researchers to investigate the long-term health effects of infection across the full disease spectrum, such as "long-covid".